4
Changes in Ownership
Guardant Health, Inc. Filed Acc 0001214130-25-000005
Director sold 26 shares at $55.63 ($1,446)
- Director acquired 68 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
POTTER MYRTLE S · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +68 | 18,307 | D | ||
| 2025-09-17 | Sale : show line 2 in the form 10b5-1 | −26 | $55.63 | $1,446 | 18,281 | D |
| Open-market sales · 26 sh · avg $55.63 · $1,446 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-15 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −68 | 69 | D |
Loading xslF345X05/wk-form4_1758143824.xml…